A pharmacokinetics study to assess the oral administration of CB7630 (abiraterone acetate) capsule formulation and tablet formulation in patients with prostate cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Dec 2012
At a glance
- Drugs Abiraterone acetate (Primary) ; Dexamethasone; Prednisolone; Prednisone
- Indications Prostate cancer
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 14 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov record
- 13 Aug 2012 Trial phase changed from I to II as reported by ClinicalTrials.gov record.